Clinical Trials
3 trialsNCT06432296 2026-05-11
Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 3 Active not recruiting
NCT06266091 2025-07-20
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Wuhan YZY Biopharma Co., Ltd.
Phase 2 Completed
NCT00836654 2009-02-05
Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group
Neovii Biotech
Phase 2/3 Completed